Skip to main content
. 2023 Jan 27;10(4):497–506. doi: 10.1002/acn3.51740

Table 1.

Summary characteristics of the included studies.

Characteristics No. of studies (no. of participants)
Eligible studies
Total no. of trials (no. of participants) 17 (19,516)
Follow‐up at least three years 11 (12,761)
Total no. of outcome events 2134
Median (IQR) % female 53 (49–59)
Median (IQR) age (years) 74 (65–80)
Country
American 12 (17,041)
European 4 (2335)
China 1 (140)
Inflammatory markers
CRP 11 (14,324)
IL‐6 15 (18,710)
TNF‐α 5 (7183)

IQR, interquartile range.